Lv2
180 积分 2024-04-03 加入
Gaps in evidence in the management of patients with intermediate-risk pulmonary arterial hypertension: Considerations following the ESC/ERS 2022 guidelines
2天前
已完结
Assessment of Riociguat-related adverse events: a disproportionality analysis utilizing the FDA adverse event reporting system database
2天前
已完结
Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in CTEPH: Insights From the RACE Trial
2天前
已完结
Clinical characteristics and aetiological analysis of 133 patients for pulmonary embolism combined with haemoptysis
2天前
已完结
Vascular Disease Patient Information Page: Post-pulmonary embolism syndrome, CTEPD, and CTEPH
2天前
已完结
Natural history of chronic thromboembolic pulmonary disease with no or mild pulmonary hypertension
4天前
已完结
Expert provider survey of longitudinal assessment in patients with pulmonary arterial hypertension
9天前
已完结
Metronomic chemotherapy and breast cancer: a critical evaluation of its role in the new landscape of therapeutics
22天前
已完结
Relapsed and refractory multiple myeloma: A systematic review and network meta‐analysis of the efficacy of novel therapies
23天前
已完结
Evidence-based recommendations for induction and maintenance treatment of newly diagnosed transplant-ineligible multiple myeloma patients
24天前
已完结
皖公网安备34019202002308
